Aytu BioScience logo
Aytu BioScience AYTU
€ 2.34 2.45%

Quartalsbericht 2025-Q4
hinzugefügt 03.02.2026

report update icon

Aytu BioScience Langfristiger Schuldenstrom 2011-2026 | AYTU

Langfristiger Schuldenstrom Jährlich Aytu BioScience

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
137 K 712 K 1.26 M 1.23 M 940 K 300 K - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
1.26 M 137 K 762 K

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Processa Pharmaceuticals Processa Pharmaceuticals
PCSA
83.6 K $ 2.3 -1.29 % $ 3.01 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 220.9 2.49 % $ 5 B danmarkDanmark
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 19.57 1.77 % $ 915 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Phathom Pharmaceuticals Phathom Pharmaceuticals
PHAT
648 K $ 10.47 4.08 % $ 763 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
1.92 M - -3.03 % $ 260 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Pliant Therapeutics Pliant Therapeutics
PLRX
1.45 M $ 1.31 2.34 % $ 80.4 M usaUSA
PMV Pharmaceuticals PMV Pharmaceuticals
PMVP
403 K $ 1.37 -1.44 % $ 72 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.33 0.76 % $ 339 M britainBritain
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
1.63 M $ 8.31 1.59 % $ 111 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
18.6 M $ 47.09 1.42 % $ 4.23 B schweizSchweiz
ChemoCentryx ChemoCentryx
CCXI
2.81 M - - $ 3.74 B usaUSA
Prelude Therapeutics Incorporated Prelude Therapeutics Incorporated
PRLD
2.74 M $ 3.26 4.49 % $ 251 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
4.18 M - - $ 2.02 B usaUSA
ProQR Therapeutics N.V. ProQR Therapeutics N.V.
PRQR
1.54 M $ 1.58 6.04 % $ 99.5 M niderlandNiderland
Enochian Biosciences Enochian Biosciences
ENOB
313 K - - $ 40.5 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Palatin Technologies Palatin Technologies
PTN
130 K $ 21.0 5.79 % $ 19.5 M usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
203 K - -74.18 % $ 955 K usaUSA
Pulmatrix Pulmatrix
PULM
429 K $ 2.12 -1.4 % $ 7.74 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
547 K $ 4.53 5.1 % $ 868 M canadaCanada
Homology Medicines Homology Medicines
FIXX
693 K - 0.77 % $ 53.4 M usaUSA